View in EDS

A phase I/II study of lenalidomide in combination with sunitinib in patients with advanced or metastatic renal cell carcinoma.

Saved in:
Bibliographic Details
Title: A phase I/II study of lenalidomide in combination with sunitinib in patients with advanced or metastatic renal cell carcinoma.
Authors: Rini B; Department of Solid Tumor Oncology, Cleveland Clinic Taussig Cancer Institute, Glickman Urological Institute, Cleveland. Electronic address: rinib2@ccf.org., Redman B; Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor., Garcia JA; Department of Solid Tumor Oncology, Cleveland Clinic Taussig Cancer Institute, Glickman Urological Institute, Cleveland., Burris HA 3rd; Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville., Li S; Celgene Corporation., Fandi A; Celgene Corporation., Beck R; Celgene Corporation., Jungnelius U; Celgene Corporation., Infante JR; Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville.
Source: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2014 Sep; Vol. 25 (9), pp. 1794-1799. Date of Electronic Publication: 2014 Jun 08.
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 24914044
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A phase I/II study of lenalidomide in combination with sunitinib in patients with advanced or metastatic renal cell carcinoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Rini+B%22">Rini B</searchLink>; Department of Solid Tumor Oncology, Cleveland Clinic Taussig Cancer Institute, Glickman Urological Institute, Cleveland. Electronic address: rinib2@ccf.org.<br /><searchLink fieldCode="AU" term="%22Redman+B%22">Redman B</searchLink>; Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor.<br /><searchLink fieldCode="AU" term="%22Garcia+JA%22">Garcia JA</searchLink>; Department of Solid Tumor Oncology, Cleveland Clinic Taussig Cancer Institute, Glickman Urological Institute, Cleveland.<br /><searchLink fieldCode="AU" term="%22Burris+HA+3rd%22">Burris HA 3rd</searchLink>; Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville.<br /><searchLink fieldCode="AU" term="%22Li+S%22">Li S</searchLink>; Celgene Corporation.<br /><searchLink fieldCode="AU" term="%22Fandi+A%22">Fandi A</searchLink>; Celgene Corporation.<br /><searchLink fieldCode="AU" term="%22Beck+R%22">Beck R</searchLink>; Celgene Corporation.<br /><searchLink fieldCode="AU" term="%22Jungnelius+U%22">Jungnelius U</searchLink>; Celgene Corporation.<br /><searchLink fieldCode="AU" term="%22Infante+JR%22">Infante JR</searchLink>; Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229007735%22">Annals of oncology : official journal of the European Society for Medical Oncology</searchLink> [Ann Oncol] 2014 Sep; Vol. 25 (9), pp. 1794-1799. <i>Date of Electronic Publication: </i>2014 Jun 08.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9007735 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1569-8041 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209237534%22">09237534 </searchLink><i>NLM ISO Abbreviation: </i>Ann Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=24914044
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/annonc/mdu212
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1794
    Titles:
      – TitleFull: A phase I/II study of lenalidomide in combination with sunitinib in patients with advanced or metastatic renal cell carcinoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Rini B
      – PersonEntity:
          Name:
            NameFull: Redman B
      – PersonEntity:
          Name:
            NameFull: Garcia JA
      – PersonEntity:
          Name:
            NameFull: Burris HA 3rd
      – PersonEntity:
          Name:
            NameFull: Li S
      – PersonEntity:
          Name:
            NameFull: Fandi A
      – PersonEntity:
          Name:
            NameFull: Beck R
      – PersonEntity:
          Name:
            NameFull: Jungnelius U
      – PersonEntity:
          Name:
            NameFull: Infante JR
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2014 Sep
              Type: published
              Y: 2014
          Identifiers:
            – Type: issn-electronic
              Value: 1569-8041
          Numbering:
            – Type: volume
              Value: 25
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: Annals of oncology : official journal of the European Society for Medical Oncology
              Type: main
ResultId 1